Karel Helman
0000-0001-7141-8074
University of Economics Prague
5 papers found
Refreshing results…
Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas
Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab
Cytarabine Nanotherapeutics with Increased Stability and Enhanced Lymphoma Uptake for Tailored Highly Effective Therapy of Mantle Cell Lymphoma
Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells
Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma
Missing publications? Search for publications with a matching author name.